Swedish Orphan Biovitrum (BIOVF)

Last Closing Price: --

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Swedish Orphan Biovitrum (BIOVF) had Net Income of $144.19M for the most recently reported fiscal quarter, ending 2026-03-31.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
$785.93M
Net Income
$144.19M
$191.12M
$594.81M
$581.68M
$204.25M
$-20.46M
$183.90M
$183.90M
$144.19M
$144.19M
$144.19M
$144.19M
$204.25M
$289.80M
345.94M
349.63M
$0.42
$0.41
Balance Sheet Financials
$1.67B
$178.76M
$7.22B
$8.89B
$2.37B
$837.24M
$2.10B
$4.47B
$4.42B
$-2.35B
$4.42B
345.85M
Cash Flow Statement Financials
$123.18M
$-956.81M
$820.72M
$113.89M
$102.84M
$-11.05M
--
--
--
Fundamental Metrics & Ratios
0.70
--
--
0.16
0.46
75.68%
25.99%
25.99%
--
23.40%
18.35%
$122.86M
--
--
--
0.09
0.34
0.77
116.22
3.26%
-6.14%
1.62%
2.74%
$12.77
$0.35
$0.35